Literature DB >> 8681445

Suppressing effect of perilla oil on azoxymethane-induced foci of colonic aberrant crypts in rats.

N Onogi1, M Okuno, C Komaki, H Moriwaki, T Kawamori, T Tanaka, H Mori, Y Muto.   

Abstract

We have investigated the modulatory effect of dietary perilla oil which is rich in the n-3 polyunsaturated fatty acid, alpha-linolenic acid, on the development of azoxymethane (AOM)-induced colonic aberrant crypt foci (ACF) in male F344 rats. Animals were given three weekly subcutaneous injections of AOM (15 mg/kg body weight) to induce ACE. The rats were fed a basal diet containing either 12% olive oil, 12% safflower oil, 12% perilla oil, 6% perilla oil plus 6% olive oil, or 3% perilla oil plus 9% olive oil for 5 weeks, starting 1 week before the first dosing of AOM. All rats were sacrificed 2 weeks after the last AOM injection. The amount of food consumed and body weight gain were identical among every dietary group. The frequency of ACF was significantly lower in the rats fed 12% perilla oil than in those fed 12% olive oil or 12% safflower oil (P < 0.01 and P < 0.05, respectively). The suppressive effect of perilla oil was dose-dependent, as the number of ACF was 20.7, 40.7 and 47.4% of those of the 12% olive oil-fed controls in rats fed 12% perilla oil, 6% perilla oil plus 6% olive oil and 3% perilla oil plus 9% olive oil, respectively. Perilla oil significantly reduced ras expression as well as the AgNORs count (cell proliferation biomarkers) in the colonic mucosa, as compared with olive oil or safflower oil (P < 0.01, respectively). Marked increases in n-3 polyunsaturated fatty acids in membrane phospholipid fractions and decreased PGE2 levels were observed in colonic mucosa of perilla oil-fed rats. These results suggest that perilla oil, even in small amounts, suppresses the development of aberrant crypt foci, and is therefore a possible preventive agent in the early stage of colon carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8681445     DOI: 10.1093/carcin/17.6.1291

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  8 in total

Review 1.  Most effective colon cancer chemopreventive agents in rats: a systematic review of aberrant crypt foci and tumor data, ranked by potency.

Authors:  Denis E Corpet; Sylviane Taché
Journal:  Nutr Cancer       Date:  2002       Impact factor: 2.900

2.  Unusual effects of some vegetable oils on the survival time of stroke-prone spontaneously hypertensive rats.

Authors:  M Z Huang; S Watanabe; T Kobayashi; A Nagatsu; J Sakakibara; H Okuyama
Journal:  Lipids       Date:  1997-07       Impact factor: 1.880

3.  Adipose tissue fatty acid composition and colon cancer: a case-control study.

Authors:  A Giuliani; F Ferrara; M Scimò; F Angelico; L Olivieri; L Basso
Journal:  Eur J Nutr       Date:  2013-11-01       Impact factor: 5.614

4.  Natural products and colon cancer: current status and future prospects.

Authors:  Subapriya Rajamanickam; Rajesh Agarwal
Journal:  Drug Dev Res       Date:  2008-11-01       Impact factor: 4.360

5.  No effects of olive oils with different phenolic content compared to corn oil on 1,2-dimethylhydrazine-induced colon carcinogenesis in rats.

Authors:  Angelo Pietro Femia; Piero Dolara; Maurizio Servili; Sonia Esposto; Agnese Taticchi; Stefania Urbani; Augusto Giannini; Maddalena Salvadori; Giovanna Caderni
Journal:  Eur J Nutr       Date:  2008-08-01       Impact factor: 5.614

Review 6.  Dietary lipids impacts on healthy ageing.

Authors:  Harumi Okuyama; Kazuyo Yamada; Daisuke Miyazawa; Yuko Yasui; Naoki Ohara
Journal:  Lipids       Date:  2007-06-02       Impact factor: 1.880

7.  Dietary conjugated linolenic acid inhibits azoxymethane-induced colonic aberrant crypt foci in rats.

Authors:  Hiroyuki Kohno; Rikako Suzuki; Ryoko Noguchi; Masashi Hosokawa; Kazuo Miyashita; Takuji Tanaka
Journal:  Jpn J Cancer Res       Date:  2002-02

8.  Omega-3 Fatty Acids and PPARgamma in Cancer.

Authors:  Iris J Edwards; Joseph T O'Flaherty
Journal:  PPAR Res       Date:  2008       Impact factor: 4.964

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.